Genome Wide Transcriptome Analysis of Dendritic Cells Identifies Genes with Altered Expression in Psoriasis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Filkor, Kata ^a   Hegedus, Zoltán ^a,b   Szász, András ^a   Tubak, Vilmos ^c   Kemény, Lajos ^d,e   Kondorosi, Éva ^a   Nagy, István ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b Zenon Bio Ltd   (Hungary)

^c Creative Laboratory Ltd   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CELL PROTEIN; INTERLEUKIN 6; MER PROTEIN; PEPTIDOGLYCAN; TNFAIP3 PROTEIN; TNFAIP8 PROTEIN; TOLL LIKE RECEPTOR 2; TRANSCRIPTOME; TYRO3 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS RELATED GENE; ARTICLE; BACTERIUM IDENTIFICATION; CELL CYCLE RELATED GENE; CELL STIMULATION; DENDRITIC CELL; DISEASE ASSOCIATION; DOWN REGULATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RELATED GENE; IN VITRO STUDY; INNATE IMMUNITY; MOLECULAR DYNAMICS; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; UPREGULATION;

APOPTOSIS; CELL CYCLE; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; IMMUNITY, INNATE; PEPTIDOGLYCAN; PSORIASIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883651668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073435     Document Type: Article

References (51)

1. Kondo T, Kawai T, Akira S, (2012) Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol 33: 449-458. doi:10.1016/j.it.2012.05.002. PubMed: 22721918.
2. Karin M, Lawrence T, Nizet V, (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124: 823-835. doi:10.1016/j.cell.2006.02.016. PubMed: 16497591.
3. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, et al. (2002) SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17: 583-591. doi:10.1016/S1074-7613(02)00446-6. PubMed: 12433365.
4. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, et al. (2002) SOCS-1 participates in negative regulation of LPS responses. Immunity 17: 677-687. doi:10.1016/S1074-7613(02)00449-1. PubMed: 12433373.
5. Bonnet MC, Preukschat D, Welz PS, van Loo G, Ermolaeva MA, et al. (2011) The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35: 572-582. doi:10.1016/j.immuni.2011.08.014. PubMed: 22000287.
6. West MA, Heagy W, (2002) Endotoxin tolerance: A review. Crit Care Med 30: S64-S73. doi:10.1097/00003246-200201001-00009. PubMed: 1189140611782563.
7. Cavaillon JM, Adib-Conquy M, (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 10: 233. doi:10.1186/cc5055. PubMed: 17044947.
8. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, et al. (2003) Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappaB signaling pathway components. J Immunol 170: 508-519. PubMed: 12496438.
9. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, et al. (2003) Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171-194. doi:10.1016/j.pharmthera.2003.08.003. PubMed: 14609719.
10. Foster SL, Hargreaves DC, Medzhitov R, (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978. PubMed: 17538624.
11. Siebert S, Robinson MD, Tintori SC, Goetz F, Helm RR, et al. (2011) Differential gene expression in the siphonophore Nanomia bijuga (Cnidaria) assessed with multiple next-generation sequencing workflows. PLOS ONE 6: e22953. doi:10.1371/journal.pone.0022953. PubMed: 21829563.
12. Lash AE, Tolstoshev CM, Wagner L, Schuler GD, Strausberg RL, et al. (2000) SAGEmap: a public gene expression resource. Genome Res 10: 1051-1060.
13. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27: 29-34. doi:10.1093/nar/27.20.e29. PubMed: 9847135.
14. Foti M, Granucci F, Pelizzola M, Beretta O, Ricciardi-Castagnoli P, (2006) Dendritic cells in pathogen recognition and induction of immune responses: a functional genomics approach. J Leukoc Biol 79: 913-916. doi:10.1189/jlb.1005547. PubMed: 16641136.
15. Joffre OP, Segura E, Savina A, Amigorena S, (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12: 557-569. doi:10.1038/nri3254. PubMed: 22790179.
16. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, et al. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869. doi:10.1084/jem.194.6.863. PubMed: 11561001.
17. Bamias G, Evangelou K, Vergou T, Tsimaratou K, Kaltsa G, et al. (2011) Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Exp Dermatol 20: 725-731. doi:10.1111/j.1600-0625.2011.01304.x. PubMed: 21672030.
18. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, et al. (2008) TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133: 415-426. doi:10.1016/j.cell.2008.03.026. PubMed: 18455983.
19. Zhang L, Shi Y, Wang Y, Zhu F, Wang Q, et al. (2011) The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Mol Immunol 48: 1209-1215. doi:10.1016/j.molimm.2011.03.001. PubMed: 21459448.
20. Zhang G, Hao C, Lou Y, Xi W, Wang X, et al. (2010) Tissue-specific expression of TIPE2 provides insights into its function. Mol Immunol 47: 2435-2442. doi:10.1016/j.molimm.2010.06.016. PubMed: 20663561.
21. Lemke G, Rothlin CV, (2008) Immunobiology of the TAM receptors. Nat Rev Immunol 8: 327-336. doi:10.1038/nri2303. PubMed: 18421305.
22. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G, (2007) TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131: 1124-1136. doi:10.1016/j.cell.2007.10.034. PubMed: 18083102.
23. Szász A, Strifler G, Vörös A, Váczi B, Tubak V, et al. (2013) The expression of TAM receptors and their ligand Gas6 is downregulated in psoriasis. J Dermatol Sci 71: 215-216. doi:10.1016/j.jdermsci.2013.04.018. PubMed: 23684948.
24. Nigg EA, (1995) Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17: 471-480. doi:10.1002/bies.950170603. PubMed: 7575488.
25. Van Parijs L, Abbas AK, (1998) Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280: 243-248. doi:10.1126/science.280.5361.243. PubMed: 9535647.
26. Wahl SM, Wen J, Moutsopoulos N, (2006) TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 213: 213-227. doi:10.1111/j.1600-065X.2006.00437.x. PubMed: 16972906.
27. Chen M, Wang J, (2010) Programmed cell death of dendritic cells in immune regulation. Immunol Rev 236: 11-27. doi:10.1111/j.1600-065X.2010.00916.x. PubMed: 20636805.
28. Hueber AJ, McInnes IB, (2007) Immune regulation in psoriasis and psoriatic arthritis--recent developments. Immunol Lett 114: 59-65. doi:10.1016/j.imlet.2007.08.009. PubMed: 17928070.
29. Nickoloff BJ, Xin H, Nestle FO, Qin JZ, (2007) The cytokine and chemokine network in psoriasis. Clin Dermatol 25: 568-573. doi:10.1016/j.clindermatol.2007.08.011. PubMed: 18021894.
30. Szász A, Strifler G, Vörös A, Váczi B, Tubak V, et al. (2013) The expression of TAM receptors and their ligand Gas6 is downregulated in psoriasis. J Dermatol Sci, 71: 215-6. PubMed: 23684948.
31. Schulz BS, Michel G, Wagner S, Süss R, Beetz A, et al. (1993) Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol 151: 4399-4406. PubMed: 7691948.
32. Lee EG, Boone DL, Chai S, Libby SL, Chien M, et al. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350-2354. doi:10.1126/science.289.5488.2350. PubMed: 11009421.
33. Hammer GE, Turer EE, Taylor KE, Fang CJ, Advincula R, et al. (2011) Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 12: 1184-1193. doi:10.1038/ni.2135. PubMed: 22019834.
34. Tavares RM, Turer EE, Liu CL, Advincula R, Scapini P, et al. (2010) The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33: 181-191. doi:10.1016/j.immuni.2010.07.017. PubMed: 20705491.
35. Kool M, van Loo G, Waelput W, De Prijck S, Muskens F, et al. (2011) The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35: 82-96. doi:10.1016/j.immuni.2011.05.013. PubMed: 21723156.
36. Jiang X, Tian H, Fan Y, Chen J, Song Y, et al. (2012) Expression of tumor necrosis factor alpha-induced protein 3 mRNA in peripheral blood mononuclear cells negatively correlates with disease severity in psoriasis vulgaris. Clin Vaccine Immunol 19: 1938-1942. doi:10.1128/CVI.00500-12. PubMed: 23054742.
37. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41: 199-204. doi:10.1038/ng.311. PubMed: 19169254.
38. Woodward MJ, de Boer J, Heidorn S, Hubank M, Kioussis D, et al. (2010) Tnfaip8 is an essential gene for the regulation of glucocorticoid-mediated apoptosis of thymocytes. Cell Death Differ 17: 316-323. doi:10.1038/cdd.2009.125. PubMed: 19730441.
39. Williams SC, (2012) New biologic drugs get under the skin of psoriasis. Nat Med 18: 638. doi:10.1038/nm0512-638. PubMed: 22561807.
40. Sockolov ME, Alikhan A, Zargari O, (2009) Non-psoriatic dermatologic uses of monoclonal antibody therapy. J Dermatol Treat 20: 319-327. doi:10.3109/09546630902936778. PubMed: 19954387.
41. Musacchio E, Valvason C, Botsios C, Ostuni F, Furlan A, et al. (2009) The tumor necrosis factor-{alpha}-blocking agent infliximab inhibits interleukin 1beta (IL-1beta) and IL-6 gene expression in human osteoblastic cells. J Rheumatol 36: 1575-1579. doi:10.3899/jrheum.081321. PubMed: 19567627.
42. Gombert M, Dieu-Nosjean MC, Winterberg F, Bünemann E, Kubitza RC, et al. (2005) CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 174: 5082-5091. PubMed: 15814739.
43. N'Diaye M, Le Ferrec E, Kronenberg F, Dieplinger H, Le Vee M, et al. (2009) TNFalpha- and NF-kappaB-dependent induction of the chemokine CCL1 in human macrophages exposed to the atherogenic lipoprotein(a). Life Sci 84: 451-457. doi:10.1016/j.lfs.2009.01.012. PubMed: 19302817.
44. Kim HO, Cho SI, Chung BY, Ahn HK, Park CW, et al. (2012) Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis. Clin Exp Dermatol 37: 521-526. doi:10.1111/j.1365-2230.2011.04295.x. PubMed: 22680616.
45. Nagy I, Filkor K, Németh T, Hamari Z, Vágvölgyi C, et al. (2011) In vitro interactions of Candida parapsilosis wild type and lipase deficient mutants with human monocyte derived dendritic cells. BMC Microbiol 11: 122. doi:10.1186/1471-2180-11-122. PubMed: 21619700.
46. Belsõ N, Széll M, Pivarcsi A, Kis K, Kormos B, et al. (2008) Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. J Invest Dermatol 128: 634-642. PubMed: 17882269.
47. Hegedus Z, Zakrzewska A, Agoston VC, Ordas A, Rácz P, et al. (2009) Deep sequencing of the zebrafish transcriptome response to mycobacterium infection. Mol Immunol 46: 2918-2930. doi:10.1016/j.molimm.2009.07.002. PubMed: 19631987.
48. Chen H, Centola M, Altschul SF, Metzger H, (1998) Characterization of gene expression in resting and activated mast cells. J Exp Med 188: 1657-1668. doi:10.1084/jem.188.9.1657. PubMed: 9802978.
49. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. Gene Ontology Consortium Nat Genet 25: 25-29.
50. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M, (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40: D109-D114. doi:10.1093/nar/gkr988. PubMed: 22080510.
51. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13. doi:10.1093/nar/gkp505. PubMed: 19033363.